AstraZeneca COVID-19 antibody drug offers 83% protection over six months
The Anglo-Swedish company also said that patients with mild-to-moderate COVID-19 showed a higher dose of the drug cut the risk of symptoms worsening by 88% when given within three days.
Health workers provide vaccination cards to residents recently inoculated with AstraZeneca vaccine against the coronavirus disease (COVID-19), inside a bus converted into a mobile vaccination site in Taguig, Metro Manila, Philippines, May 21, 2021(photo credit: REUTERS/LISA MARIE DAVID)ByREUTERS
